Study of adverse events in an accredited secondary hospital of CearÃ: an approach to risk management

• Autor(a) principal: Milena Pontes Portela Bezerra
• Data de Publicação: 2011
• Tipo de documento: Dissertação
• Idioma: por
• Título da fonte: Biblioteca Digital de Teses e Dissertações da UFC
• Texto Completo: http://www.teses.ufc.br/tde_busca/arquivo.php?codArquivo=7401
• topic: Risk Management; Adverse Drug Reaction Reporting Systems; Adverse Effects.; FARMACIA

Study of adverse events in an accredited secondary hospital of CearÃ: an approach to risk management. Author: Milena Pontes Portela Beserra. Supervisor: ProfÂ. Dr Marta Maria de FranÃa Fonteles. [Master degreeâs dissertation. Post Graduation in Pharmaceutical Science. Department of Pharmacy â Federal University of CearÃ]. BACKGROUND: Hospital Risk Management acts in the prevention, detection, control or eliminate risks that could cause harm to patients, in Brazil this concept was implemented in 2001 by the National Agency for Sanitary Surveillance (Anvisa), Ministry of Health with the project Sentinel Hospitals, and currently brings together nearly two hundred institutions. It consists basically of three pillars: pharmacovigilance, haemovigilance and technical surveillance. Indicators of results and adverse events are fundamental tools of quality by pointing out aspects of care that can be improved by making patient care without risks and failures, and therefore safer. In order to improve the quality of healthcare services in recent decades had the strength of the Hospital Accreditation Program consisting of external evaluation system that verifies the compliance of the structure and care processes with the adopted set of standards previously established. OBJECTIVES: To study adverse events suffered by hospitalized patients or that were related to drugs and related in a public secondary hospital accredited by National Accreditation Organization (ONA), in 2010, contextualizing the risk management approach in the hospital. METHODS: We conducted a retrospective documentary base at the Hospital General Dr. Waldemar Alcantara (HGWA) a survey of all reports of adverse drug reactions (ADRs), reactions to blood products and technical defects of materials, equipment and drugs, studying, and the risk management with a focus on pharmacovigilance, haemovigilance and technical surveillance, respectively. RESULTS AND DISCUSSION: There have been 271 events, with 166 (61.3%) RAM, 64 (23.6%) technical defects, 41 (15.1%) transfusion reactions. We found a higher number of RAM in patients with extreme age and use of antimicrobials, as well as previously reported. The main reported ADRs were dermatological and medical groups were more involved antimicrobials for systemic use. The main blood component was transfused red blood cells, is also a major cause of anemia, transfusion reactions and the main indication. The most transfusion reactions reported were fever (55.6%), dyspnea (8.9%) and urticaria (8.9%), these reactions were immediate in 92.7% of cases, they occurred in up to 24 hours after transfusion. Techniques have been reported 64 complaints of 40 different products, the main products cited were: saline 100 mL closed system (14.1%) and micropore tape (7.8%). Had the potential to cause direct harm to patients 81.3% the complaints and the nursing staff was the main notifier. CONCLUSION: The HGWA presents a program of effective risk management, maintaining and working on positive indicators for the safety of the patient. Even more important is to note that you can perform a quality service in terms of risk management, even when it comes to a public hospital in northeastern Brazil with financial constraints.